An accelerated Parkinson's disease monkey model using AAV-α-synuclein plus poly(ADP-ribose).

Area of Science:

• Neuroscience
• Neurology
• Pathology

Background:

• The exact causes of Parkinson's disease (PD) are unknown.
• Existing animal models for PD research are limited, hindering progress in understanding disease mechanisms and developing effective treatments.

Purpose of the Study:

• To develop a new cynomolgus monkey model that accurately replicates key features of Parkinson's disease.
• To facilitate research into the pathogenesis of PD and accelerate the development of therapeutic strategies.

Main Methods:

• Adeno-associated virus (AAV)-mediated overexpression of alpha-synuclein in the substantia nigra.
• Intrastriatal injection of poly(ADP-ribose) (PAR).
• Assessment of pathological, behavioral, imaging, and transcriptomic changes.

Main Results:

• The model exhibited accelerated pathological processes, including dopaminergic neuron degeneration and Lewy body formation.
• Hallmarks of neuroinflammation, including microglial and astrocyte activation, were observed.
• Behavioral, imaging (dopamine transporter), and transcriptomic profiles closely mirrored those seen in human PD patients.

Conclusions:

• This novel cynomolgus monkey model provides a valuable tool for investigating the roles of alpha-synuclein and PAR in PD pathogenesis.
• The model's fidelity to human PD pathology and phenotypes will aid in the discovery and testing of new therapeutic interventions.